High-dose radioimmunotherapy/chemotherapy and autologous stem cell transplantation (ASCT) for poor risk and relapsed CD20+non-Hodgkin's lymphoma (NHL): Early feasibility report.

被引：0
作者：
Raubitschek, A
Nademanee, A
Molina, A
Rodriguez, R
White, C
Forman, S
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Idec Pharmaceut Corp, San Diego, CA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5372
引用
收藏
页码：374B / 375B
页数：2
相关论文
共 50 条
[31]   KINETIC OF HEMATOLOGICAL TOXICITIES IN PATIENTS (PTS) TREATED WITH RADIOIMMUNOTHERAPY (RIT) AND AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR NON-HODGKIN'S LYMPHOMA (NHL) [J].
Pavone, V. ;
Messa, A. R. ;
Del Casale, C. D. C. ;
Rana, A. ;
Mele, A. ;
Greco, G. ;
De Francesco, R. ;
Sibilla, S. ;
Frusciante, V. ;
Frusciante, V. ;
Varraso, A. ;
Dicembrino, F. ;
Tabacco, P. ;
Caputo, M. ;
Ostuni, A. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 :430-430
[32]   High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: Prognostic features and outcomes [J].
Engelhardt, Brian G. ;
Holland, Derek W. ;
Brandt, Stephen J. ;
Chinratanalab, Wichai ;
Goodman, Stacey A. ;
Greer, John P. ;
Jagasia, Madan H. ;
Kassim, Adetola A. ;
Morgan, David S. ;
Ruffner, Katherine L. ;
Schuening, Friedrich G. ;
Wolff, Steven ;
Bitting, Rhonda ;
Sulur, Paulgun ;
Stein, Richard S. .
LEUKEMIA & LYMPHOMA, 2007, 48 (09) :1728-1735
[33]   A phase I/II trial of high-dose radioimmunotherapy (RIT) with Zevalin in combination with high-dose etoposide (VP-16) and cyclophosphamide (CY) followed by autologous stem cell transplant (ASCT) in patients with poor-risk or relapsed B-cell non-Hodgkin's lymphoma (NHL). [J].
Nademanee, A ;
Molina, A ;
Forman, SJ ;
Kogut, N ;
Yamauchi, D ;
An, L ;
White, CA ;
Raubitschek, A .
BLOOD, 2002, 100 (11) :182A-182A
[34]   Front-line double high dose chemotherapy (HDCT) with DICEP-BEAM and autologous stem cell transplantation (ASCT) for poor prognosis aggressive non-Hodgkin's lymphoma (NHL) [J].
Stewart, D ;
Valentine, K ;
Balogh, A ;
Morris, D ;
Brown, C ;
Jones, A ;
Russell, JA .
ANNALS OF ONCOLOGY, 2005, 16 :99-99
[35]   BUCYVP16 and early autologous stem cell transplantation (ASCT) in high risk follicular non Hodgkin lymphomas (NHL). [J].
Pavone, V ;
Guarini, A ;
Gaudio, F ;
Quintana, G ;
Perrone, T ;
Tarantini, G ;
Rana, A ;
Liso, V .
BONE MARROW TRANSPLANTATION, 1998, 21 :S176-S176
[36]   Effect of follicularity on outcome of high-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) for large cell non-Hodgkin's lymphoma. [J].
Vose, J ;
Lynch, J ;
Bierman, P ;
Anderson, J ;
Kessinger, A ;
Armitage, JO .
BLOOD, 1996, 88 (10) :476-476
[37]   High-dose therapy and autologous stem cell transplantation (ASCT) for poor-risk and relapsed non-Hodgkin's lymphoma (NHL): Long-term follow-up results and analysis of prognostic factors in 369 patients. [J].
Nademanee, A ;
Molina, A ;
Dagis, AC ;
O'Donnell, MR ;
Snyder, DS ;
Stein, A ;
Parker, PH ;
Wong, KK ;
Kashyap, A ;
Spielberger, RS ;
Fung, HC ;
Krishnan, A ;
Bhatia, R ;
Rodriquez, R ;
Vora, N ;
Sniecinski, I ;
Niland, JC ;
Forman, SJ .
BLOOD, 1999, 94 (10) :170A-170A
[38]   MAMI salvage therapy and high-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation in refractory or relapsing non Hodgkin's lymphoma (NHL). [J].
Bendahmane, B ;
Bourhis, JH ;
Munck, JN ;
Koscielny, S ;
Decaudin, D ;
Brault, P ;
Castagna, L ;
Bosq, J ;
Ibrahim, A ;
Naccache, P ;
Ulusakarya, A ;
Pico, JL ;
Hayat, M .
BLOOD, 1996, 88 (10) :3852-3852
[39]   Phase I clinical trial of Zevalin (90Y-ibritumomab) in patients with B-cell non-Hodgkin's lymphoma (NHL) with relapsed disease following high-dose chemotherapy and autologous stem cell transplantation (ASCT). [J].
Vose, JM ;
Bierman, PJ ;
Lynch, JC ;
Bociek, GR ;
Multani, PS ;
Armitage, JO .
BLOOD, 2003, 102 (11) :30A-30A
[40]   Late relapses following autologous hematopoietic stem cell (ASCT) transplantation for non-Hodgkin's lymphoma (NHL). [J].
Bierman, PJ ;
Vose, JM ;
Lynch, JC ;
Bociek, RG ;
Morris, ME ;
Armitage, JO .
BLOOD, 1999, 94 (10) :610A-610A
12345